Australia markets closed

CKX Lands, Inc. (CKX)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.51+0.08 (+0.60%)
As of 03:56PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 27.40M
Enterprise value 18.32M
Trailing P/E 193.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.29
Price/book (mrq)1.50
Enterprise value/revenue 12.33
Enterprise value/EBITDA -789.12

Trading information

Stock price history

Beta (5Y monthly) 0.05
52-week change 336.88%
S&P500 52-week change 321.83%
52-week high 314.25
52-week low 39.42
50-day moving average 313.39
200-day moving average 312.39

Share statistics

Avg vol (3-month) 32.25k
Avg vol (10-day) 3960
Shares outstanding 52.03M
Implied shares outstanding 62.03M
Float 81.35M
% held by insiders 131.24%
% held by institutions 116.57%
Shares short (28 Mar 2024) 4555
Short ratio (28 Mar 2024) 40.27
Short % of float (28 Mar 2024) 40.04%
Short % of shares outstanding (28 Mar 2024) 40.03%
Shares short (prior month 29 Feb 2024) 41.78k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.87
Payout ratio 40.00%
Dividend date 310 Apr 2017
Ex-dividend date 404 Apr 2018
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.62%
Operating margin (ttm)51.96%

Management effectiveness

Return on assets (ttm)-0.10%
Return on equity (ttm)0.80%

Income statement

Revenue (ttm)1.49M
Revenue per share (ttm)0.75
Quarterly revenue growth (yoy)143.90%
Gross profit (ttm)N/A
EBITDA -23.22k
Net income avi to common (ttm)142.96k
Diluted EPS (ttm)0.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.07M
Total cash per share (mrq)4.56
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)18.95
Book value per share (mrq)9.20

Cash flow statement

Operating cash flow (ttm)876.95k
Levered free cash flow (ttm)874.71k